Mannkind (MNKD) Other Non-Current Assets (2010 - 2026)

Mannkind (MNKD) reported Other Non-Current Assets of $747000.0 for Q1 2026, down 97.34% year-over-year from $28.1 million in Q1 2025, and down 96.29% quarter-over-quarter from $20.1 million in Q4 2025.

Mannkind (MNKD) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Other Non-Current Assets data on file, last reported at $747000.0 in Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $747000.0, down 97.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $747000.0 (down 97.34% YoY), and the FY2025 annual result was $20.1 million, down 24.77% from the prior year.
  • Other Non-Current Assets slipped to $747000.0 in Q1 2026 per MNKD's latest filing, from $20.1 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $28.1 million in Q1 2025 and troughed at $732000.0 in Q2 2024.
  • A 5-year average of $13.0 million and a median of $12.1 million in 2022 frame the typical range for Other Non-Current Assets.
  • The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets surged 2580.87% in 2025, then sank 97.34% in 2026.
  • A 5-year view of Other Non-Current Assets shows it stood at $9.7 million in 2022, then dropped by 23.59% to $7.4 million in 2023, then soared by 260.32% to $26.8 million in 2024, then fell by 24.77% to $20.1 million in 2025, then tumbled by 96.29% to $747000.0 in 2026.
  • Business Quant data shows MNKD's Other Non-Current Assets at $747000.0 in Q1 2026, $20.1 million in Q4 2025, and $19.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 747,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 747,000.00
Dec 31, 2025 20.13 Mn
Sep 30, 2025 19.13 Mn
Jun 30, 2025 19.62 Mn
Mar 31, 2025 28.06 Mn
Dec 31, 2024 26.76 Mn
Sep 30, 2024 735,000.00
Jun 30, 2024 732,000.00
Mar 31, 2024 7.45 Mn
Dec 31, 2023 7.43 Mn
Sep 30, 2023 8.05 Mn
Jun 30, 2023 8.35 Mn
Mar 31, 2023 16.38 Mn
Dec 31, 2022 9.72 Mn
Sep 30, 2022 17.31 Mn
Jun 30, 2022 17.51 Mn
Mar 31, 2022 12.06 Mn
Dec 31, 2021 8.44 Mn
Sep 30, 2021 6.09 Mn
Jun 30, 2021 5.80 Mn